VS
Evolve Global Healthcare Enhanced Yield ETF (LIFE) and BMO Global Health Care Fund Active ETF Series (ZGHC) offer distinct profiles for Canadian ETF investors. A direct comparison shows that LIFE focuses its top 3 sector exposures on Healthcare, while ZGHC leans towards Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals. When evaluating costs, LIFE features a management fee (MER) of 0.45%, compared to 1.02% for ZGHC. Performance-wise, LIFE has returned 3.83% year-to-date with +$26 M in net flows, whereas ZGHC is at 5.02% with +$9 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
LIFE
ZGHC
| AuM | $259.33 M | $11.79 M |
| Management Fees | 0.45% | 1.02% |
| Exp. ratio | 0.65% | 0.82% |
| Tracking Difference | - | - |
Historical performance and flows
As of July 21, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | LIFE | +3.94% | +3.13% | -3.83% | +7.87% | -2.75% |
ZGHC | +4.72% | +11.57% | +5.02% | +21.79% | +27.51% | |
| Flows | LIFE | +$2 M | -$7 M | +$26 M | +$65 M | +$102 M |
ZGHC | +$2 M | +$3 M | +$9 M | -$110 M | +$11 M |
LIFE vs ZGHC exposure
Countries
LIFE
USA
66.45%
Switzerland
10.21%
United Kingdom
9.14%
Other
14.20%
ZGHC
USA
79.11%
Switzerland
9.37%
Other
11.52%
Sectors
LIFE
Healthcare
101.40%
ZGHC
Healthcare
97.85%
As of July 21, 2026
Top 10 Holdings
LIFE
Novo Nordisk A/S
6.45%
Eli Lilly & Co.
6.41%
AbbVie, Inc.
6.18%
Johnson & Johnson
5.44%
Merck & Co., Inc.
5.29%
Amgen, Inc.
5.19%
Novartis AG
5.11%
Roche Holding AG
5.11%
Danaher Corp.
5.10%
Thermo Fisher Scientific, Inc.
5.07%
ZGHC
Eli Lilly & Co.
11.63%
Johnson & Johnson
7.56%
UnitedHealth Group, Inc.
7.43%
Merck & Co., Inc.
6.51%
AbbVie, Inc.
5.90%
AstraZeneca PLC
4.89%
argenx SE
4.40%
Novartis AG
3.87%
Gilead Sciences, Inc.
3.25%
BrightSpring Health Services, Inc.
3.11%
Diversification
LIFE
Total weight of top 10 holdings out of 20 total
55.34%
ZGHC
Total weight of top 10 holdings out of 119 total
58.55%
Characteristics
Compare
LIFE
ZGHC
| Provider | Evolve ETFs | BMO |
| Management | Actively managed | Actively managed |
| Benchmark | - | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 12.01% | 0.00% |
| Meets ESG criteria | No | No |
| Inception Date | October 25, 2017 | June 26, 2023 |
Frequently asked questions about LIFE and ZGHC
Which ETF has performed better year to date: LIFE or ZGHC?
As of July 21, 2026, LIFE has returned -3.83% year to date, while ZGHC has returned 5.02%. ZGHC is ahead on YTD performance.
Which ETF is larger by assets under management: LIFE or ZGHC?
As of July 21, 2026, LIFE manages $259.33 M in assets, while ZGHC manages $11.79 M. LIFE is the larger fund by AUM.
How are LIFE and ZGHC managed?
LIFE is actively managed by Evolve ETFs. It does not track an index. ZGHC is actively managed by BMO. It does not track an index.
What sectors do LIFE and ZGHC emphasize?
LIFE is most exposed to Healthcare. ZGHC is most exposed to Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals.
Which ETF is attracting more investor flows: LIFE or ZGHC?
Year to date, LIFE has seen +$25.92 M in net flows, compared with +$8.50 M for ZGHC. LIFE has attracted more net investor money so far.
How do the fees of LIFE and ZGHC compare?
LIFE has an expense ratio of 0.65%, while ZGHC has an expense ratio of 0.82%.
What are the top holdings of LIFE and ZGHC?
LIFE's largest holdings include Novo Nordisk A/S, Eli Lilly & Co., and AbbVie, Inc.. ZGHC's top holdings include Eli Lilly & Co., Johnson & Johnson, and UnitedHealth Group, Inc..
Which ETF is more diversified: LIFE or ZGHC?
LIFE holds 20 securities, while ZGHC holds 117. On holdings count, ZGHC is the more diversified portfolio.
Recent articles about LIFE and ZGHC
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.